Hepatitis C Antibodies

"Hepatitis C Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.

Descriptor ID	D018937
MeSH Number(s)	D12.776.124.486.485.114.254.450.510 D12.776.124.790.651.114.254.450.510 D12.776.377.715.548.114.254.450.510
Concept/Terms	Hepatitis C Antibodies Hepatitis C Antibodies Hepatitis C Virus Antibodies HCV Antibodies Anti-HCV Antibodies Anti HCV Antibodies Anti-Hepatitis C Virus Antibodies Anti Hepatitis C Virus Antibodies

Below are MeSH descriptors whose meaning is more general than "Hepatitis C Antibodies".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Antibodies, Viral [D12.776.124.486.485.114.254]
Hepatitis Antibodies [D12.776.124.486.485.114.254.450]
Hepatitis C Antibodies [D12.776.124.486.485.114.254.450.510]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Antibodies, Viral [D12.776.124.790.651.114.254]
Hepatitis Antibodies [D12.776.124.790.651.114.254.450]
Hepatitis C Antibodies [D12.776.124.790.651.114.254.450.510]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Antibodies, Viral [D12.776.377.715.548.114.254]
Hepatitis Antibodies [D12.776.377.715.548.114.254.450]
Hepatitis C Antibodies [D12.776.377.715.548.114.254.450.510]

Below are MeSH descriptors whose meaning is related to "Hepatitis C Antibodies".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C Antibodies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C Antibodies" by people in this website by year, and whether "Hepatitis C Antibodies" was a major or minor topic of these publications.

Bar chart showing 10 publications over 10 distinct years, with a maximum of 1 publications in 2000 and 2002 and 2005 and 2006 and 2010 and 2013 and 2014 and 2015 and 2020 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2002	0	1	1
2005	0	1	1
2006	1	0	1
2010	0	1	1
2013	0	1	1
2014	0	1	1
2015	1	0	1
2020	1	0	1
2023	0	1	1

Below are the most recent publications written about "Hepatitis C Antibodies" by people in Profiles.

Cowan E, Brandspiegel S, Araki B, O'Brien-Lambert C, Merchant R, Buckler DG, Eiting E, Calderon Y. Relationship of hepatitis C risk to hepatitis C test acceptance among adult patients participating in an ED hepatitis C screening programme. Emerg Med J. 2023 May; 40(5):341-346.

View in: PubMed
Cowan EA, Dinani A, Brandspiegel S, O'Brien-Lambert C, Zaheer J, Eiting E, Loo G, Calderon Y. Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City. J Emerg Med. 2021 Mar; 60(3):299-309.

View in: PubMed
Kohli A, Funk E, Burbelo P, Barrett L, Meissner EG, Santich B, Shaffer A, Johl J, Sidharthan S, Moir S, Kottilil S, Fauci AS. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. J Med Virol. 2015 Apr; 87(4):544-52.

View in: PubMed
Yehia BR, Herati RS, Fleishman JA, Gallant JE, Agwu AL, Berry SA, Korthuis PT, Moore RD, Metlay JP, Gebo KA. Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. PLoS One. 2014; 9(7):e102766.

View in: PubMed
Heller T, Werner JM, Rahman F, Mizukoshi E, Sobao Y, Gordon AM, Sheets A, Sherker AH, Kessler E, Bean KS, Herrine SK, Stevens M, Schmitt J, Rehermann B. Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study. J Infect Dis. 2013 Sep; 208(6):1020-5.

View in: PubMed
Santos C, Herrine SK. Making the best of a bad situation: early chronic nosocomial HCV infection. Dig Dis Sci. 2010 Jun; 55(6):1509-11.

View in: PubMed
Semmo N, Lucas M, Krashias G, Lauer G, Chapel H, Klenerman P. Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy. Blood. 2006 Jun 01; 107(11):4570-1.

View in: PubMed
Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet. 2005 Jan 22-28; 365(9456):327-9.

View in: PubMed
Herrine SK, Michael B, Ma WL, Rossi S, Dunn SR, Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroenterol. 2002 Oct; 97(10):2619-22.

View in: PubMed
Mandal AK, Kraus ES, Samaniego M, Rai R, Humphreys SL, Ratner LE, Maley WR, Burdick JF. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant. 2000 Aug; 14(4 Pt 2):391-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement